ReviewAnnals of the rheumatic diseases2005

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

D E Furst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.